A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA

© 2014 The American Society of Gene and Cell Therapy. Protein-based methods of targeted short-interfering RNA (siRNA) delivery have the potential to solve some of the problems faced by nanoparticle-based methods, such as poor pharmacokinetics and biodistribution, low tumor penetration, and polydispe...

Full description

Bibliographic Details
Main Authors: Liu, DV, Yang, NJ, Wittrup, KD
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering
Format: Article
Language:English
Published: Elsevier BV 2021
Online Access:https://hdl.handle.net/1721.1/134532
_version_ 1826194089379364864
author Liu, DV
Yang, NJ
Wittrup, KD
author2 Massachusetts Institute of Technology. Department of Chemical Engineering
author_facet Massachusetts Institute of Technology. Department of Chemical Engineering
Liu, DV
Yang, NJ
Wittrup, KD
author_sort Liu, DV
collection MIT
description © 2014 The American Society of Gene and Cell Therapy. Protein-based methods of targeted short-interfering RNA (siRNA) delivery have the potential to solve some of the problems faced by nanoparticle-based methods, such as poor pharmacokinetics and biodistribution, low tumor penetration, and polydispersity. However, protein-based targeted delivery has been limited to fusion proteins with polycationic peptides as siRNA carriers, whose high charge density in some cases results in undesirable biophysical and in vivo properties. Here, we present a fully proteinaceous, multiagent approach for targeted siRNA delivery to epidermal growth factor receptor (EGFR), using a nonpolycationic carrier for siRNA. Each agent contributes a fundamentally different mechanism of action that work together for potent targeted RNA interference. The first agent is an EGFR-targeted fusion protein that uses a double-stranded RNA-binding domain as a nonpolycationic siRNA carrier. This double-stranded RNA-binding domain fusion protein can deliver siRNA to the endosomes of an EGFR-expressing cell line. A second agent delivers the cholesterol-dependent cytolysin, perfringolysin O, in a targeted manner, which enhances the endosomal escape of siRNA and induces gene silencing. A third agent that clusters EGFR increases gene-silencing potency and decreases cytolysin toxicity. Altogether, this system is potent, with only 16 nmol/l siRNA required for gene silencing and a therapeutic window that spans two orders of magnitude of targeted cytolysin concentrations.
first_indexed 2024-09-23T09:50:19Z
format Article
id mit-1721.1/134532
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T09:50:19Z
publishDate 2021
publisher Elsevier BV
record_format dspace
spelling mit-1721.1/1345322023-02-23T15:19:15Z A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA Liu, DV Yang, NJ Wittrup, KD Massachusetts Institute of Technology. Department of Chemical Engineering Massachusetts Institute of Technology. Department of Biological Engineering Koch Institute for Integrative Cancer Research at MIT © 2014 The American Society of Gene and Cell Therapy. Protein-based methods of targeted short-interfering RNA (siRNA) delivery have the potential to solve some of the problems faced by nanoparticle-based methods, such as poor pharmacokinetics and biodistribution, low tumor penetration, and polydispersity. However, protein-based targeted delivery has been limited to fusion proteins with polycationic peptides as siRNA carriers, whose high charge density in some cases results in undesirable biophysical and in vivo properties. Here, we present a fully proteinaceous, multiagent approach for targeted siRNA delivery to epidermal growth factor receptor (EGFR), using a nonpolycationic carrier for siRNA. Each agent contributes a fundamentally different mechanism of action that work together for potent targeted RNA interference. The first agent is an EGFR-targeted fusion protein that uses a double-stranded RNA-binding domain as a nonpolycationic siRNA carrier. This double-stranded RNA-binding domain fusion protein can deliver siRNA to the endosomes of an EGFR-expressing cell line. A second agent delivers the cholesterol-dependent cytolysin, perfringolysin O, in a targeted manner, which enhances the endosomal escape of siRNA and induces gene silencing. A third agent that clusters EGFR increases gene-silencing potency and decreases cytolysin toxicity. Altogether, this system is potent, with only 16 nmol/l siRNA required for gene silencing and a therapeutic window that spans two orders of magnitude of targeted cytolysin concentrations. 2021-10-27T20:05:26Z 2021-10-27T20:05:26Z 2014-05-13 2019-09-13T18:16:14Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/134532 en 10.1038/mtna.2014.15 Molecular Therapy - Nucleic Acids Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier BV PMC
spellingShingle Liu, DV
Yang, NJ
Wittrup, KD
A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA
title A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA
title_full A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA
title_fullStr A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA
title_full_unstemmed A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA
title_short A nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of siRNA
title_sort nonpolycationic fully proteinaceous multiagent system for potent targeted delivery of sirna
url https://hdl.handle.net/1721.1/134532
work_keys_str_mv AT liudv anonpolycationicfullyproteinaceousmultiagentsystemforpotenttargeteddeliveryofsirna
AT yangnj anonpolycationicfullyproteinaceousmultiagentsystemforpotenttargeteddeliveryofsirna
AT wittrupkd anonpolycationicfullyproteinaceousmultiagentsystemforpotenttargeteddeliveryofsirna
AT liudv nonpolycationicfullyproteinaceousmultiagentsystemforpotenttargeteddeliveryofsirna
AT yangnj nonpolycationicfullyproteinaceousmultiagentsystemforpotenttargeteddeliveryofsirna
AT wittrupkd nonpolycationicfullyproteinaceousmultiagentsystemforpotenttargeteddeliveryofsirna